Nurix Therapeutics's total assets for Q1 2025 were $615.04M, a decrease of -8.11% from the previous quarter. NRIX total liabilities were $134.13M for the fiscal quarter, a -5.78% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.